Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) NSE

1,737.90

-18(-1.03%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap4.07T
Enterprise Value3.98T
P/E Ratio39.88
PEG Ratio57.56
Price/Sales Ratio7.58
Price/Book Ratio5.36
Enterprise/Revenue7.45
Enterprise/EBITDA24.75

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.19
Operating Margin0.44

Management Effectiveness

Return On Assets0.1
Return On Equity0.14

Income Statement

Revenue525.78B
Revenue/Share229.08
Gross Profit410.2B
EBITDA149.68B
Net Income109.29B
Diluted EPS45.6

Balance Sheet

Total Cash278.8B
Total Cash/Share116.2
Total Debt52.15B
Total Debt/Equity0.07
Current Ratio2.57
Book Value Per Share325.62

Price History

52-Week Change-4.51
52-Week High1,910
52-Week Low1,548
Moving Average 50 Days1,747.6
Moving Average 200 Days1,696.34

Statistics

Average Volume2.07M
Shares Outstanding2.4B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate16
Trailing Annual Dividend Yield0.92
Payout Ratio0
Last Split Factor2:1
Last Split DateJuly 29, 2013